Activity of the kynurenine pathway and its interplay with immunity in patients with pulmonary arterial hypertension

Heart

Volumn 102, Issue 3, 2016, Pages 230-237

  Jasiewicz, Malgorzata ^a   Moniuszko, Marcin ^a   Pawlak, Dariusz ^a   Knapp, Malgorzata ^a   Rusak, Malgorzata ^a   Kazimierczyk, Remigiusz ^a   Musial, Wlodzimierz Jerzy ^a   Dabrowska, Milena ^a   Kaminski, Karol Adam ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYKYNURENINE; ANTHRANILIC ACID; BRAIN NATRIURETIC PEPTIDE; KYNURENIC ACID; KYNURENINE; TRYPTOPHAN; 3-HYDROXYKYNURENINE; ANTHRANILIC ACID DERIVATIVE;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HUMAN; IMMUNITY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; POLAND; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN INTERACTION; PULMONARY HYPERTENSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; UPREGULATION; AGED; ANALOGS AND DERIVATIVES; AREA UNDER THE CURVE; BLOOD; CASE CONTROL STUDY; DOPPLER ECHOCARDIOGRAPHY; EXERCISE TEST; FLOW CYTOMETRY; IMMUNOLOGY; RECEIVER OPERATING CHARACTERISTIC; TH17 CELL;

ADULT; AGED; AREA UNDER CURVE; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TEST; FEMALE; FLOW CYTOMETRY; HUMANS; HYPERTENSION, PULMONARY; KYNURENIC ACID; KYNURENINE; MALE; MIDDLE AGED; ORTHO-AMINOBENZOATES; PROSPECTIVE STUDIES; ROC CURVE; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRYPTOPHAN;

EID: 84958986307     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-308581     Document Type: Article

References (29)

1. Rabinovitch M, Guignabert C, Humbert M, et al. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res 2014;115:165-75.
2. Jasiewicz M, Kowal K, Kowal-Bielecka O, et al. Serum levels of CD163 and TWEAK in patients with pulmonary arterial hypertension. Cytokine 2014;66:40-5.
3. Jasiewicz M, Knapp M, Waszkiewicz E, et al. Potential pathogenic role of soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin in patients with pulmonary arterial hypertension. Pol Arch Med Wewn 2014;124:579-86.
4. Maddur MS, Miossec P, Kaveri SV, et al. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 2012;181:8-18.
5. Ulrich S, Nicolls MR, Taraseviciene L, et al. Increased regulatory and decreased CD8 + cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension. Respiration 2008;75:272-80.
6. Huertas A, Tu L, Gambaryan N, et al. Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension. Eur Respir J 2012;40:895-904.
7. Oxenkrug GF. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging. Ann N Y Acad Sci 2007;1122:35-49.
8. van Baren N, Van den Eynde BJ. Tryptophan-degrading enzymes in tumoral immune resistance. Front Immunol 2015;6:34.
9. Pawlak K, Domaniewski T, Mysliwiec M, et al. The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease. Atherosclerosis 2009;204:309-14.
10. Pawlak K, Mysliwiec M, Pawlak D. Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients. Thromb Res 2010;125:e40-5.
11. Galiè N, Hoeper M, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
12. Pawlak D, Tankiewicz A, Mysliwiec P, et al. Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure. Nephron 2002;90:328-35.
13. Moniuszko M, Grubczak K, Kowal K, et al. Development of asthmatic response upon bronchial allergen challenge is associated with dynamic changes of interleukin-10-producing and interleukin-10-responding CD4+ T cells. Inflammation 2014;37:1945-56.
14. Moniuszko M, Kowal K, Zukowski S, et al. Frequencies of circulating CD4+CD25 +CD127low cells in atopics are altered by bronchial allergen challenge. Eur J Clin Invest 2008;38:201-4.
15. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013;62:D34-41.
16. Tazelaar HD, Myers JL, Drage CW, et al. Pulmonary disease associated with L-tryptophan-induced eosinophilic myalgia syndrome. Clinical and pathologic features. Chest 1990;97:1032-6.
17. Yakovlevitch M, Siegel M, Hoch DH, et al. Pulmonary hypertension in a patient with tryptophan-induced eosinophilia-myalgia syndrome. Am J Med 1991;90:272-3.
18. Munn DH, Shafizadeh E, Attwood JT, et al. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999;189:1363-72.
19. Terness P, Bauer TM, Röse L, et al. Inhibition of allogeneic T cell proliferation by indoleamine 2, 3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 2002;196:447-57.
20. Fallarino F, Grohmann U, You S, et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells. J Immunol 2006;176:6752-61.
21. Pilotte L, Larrieu P, Stroobant V, et al. Reversal of tumoral immune resistance by inhibition of tryptophan 2, 3-dioxygenase. Proc Natl Acad Sci USA 2012;109:2497-502.
22. Kanai M, Funakoshi H, Takahashi H, et al. Tryptophan 2, 3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol Brain 2009;2:8.
23. Nguyen NT, Kimura A, Nakahama T, et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad Sci USA 2010;107:19961-6.
24. Perros F, Dorfmüller P, Souza R, et al. Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension. Eur Respir J 2007;29:462-8.
25. Wang Y, Liu H, McKenzie G, et al. Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med 2010;16:279-85.
26. Gaowa S, Zhou W, Yu L, et al. Effect of Th17 and Treg axis disorder on outcomes of pulmonary arterial hypertension in connective tissue diseases. Mediators Inflamm 2014;2014:247372.
27. Hashimoto-Kataoka T, Hosen N, Sonobe T, et al. Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension. Proc Natl Acad Sci USA 2015;112:E2677-86.
28. Chu Y, Xiangli X, Xiao W. Regulatory T cells protect against hypoxiainduced pulmonary arterial hypertension in mice. Mol Med Rep 2015;11:3181-7.
29. Krause R, Zollner-Schwetz I, Salzer HJ, et al. Elevated levels of interleukin 17A and kynurenine in candidemic patients, compared with levels in noncandidemic patients in the intensive care unit and those in healthy controls. J Infect Dis 2015;211:445-51.